# ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.

> **NCT01589146** · PHASE3 · UNKNOWN · sponsor: **University Of Perugia** · enrollment: 400 (estimated)

## Conditions studied

- The Primary Study Objective is to Assess the Efficacy and
- Safety of Extended 4-week Heparin Prophylaxis Compared to
- Prophylaxis Given for 8±2 Days After Planned Laparoscopic
- Surgery for Colorectal Cancer.
- The Clinical Benefit Will be Evaluated as the Difference in
- the Incidence of VTE or VTE-related Death Occurring Within 30 Days
- From Surgery in the Two Study Groups.

## Interventions

- **DRUG:** Heparin, Low-Molecular-Weight

## Key facts

- **NCT ID:** NCT01589146
- **Lead sponsor:** University Of Perugia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2012-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01589146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01589146, "ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01589146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*